{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:45:46Z","timestamp":1790826346181,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Community's Seventh Framework Program","award":["HEALTH-F7-2009-241745"],"award-info":[{"award-number":["HEALTH-F7-2009-241745"]}]},{"name":"NEWTBVAC, Research Grant from M\u00e9rieux Alliance"},{"name":"Swiss National Foundation","award":["310030-149571"],"award-info":[{"award-number":["310030-149571"]}]},{"name":"BMRC-SERC Diagnostic","award":["1121480006"],"award-info":[{"award-number":["1121480006"]}]},{"DOI":"10.13039\/501100000276","name":"Department of Health, UK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.vaccine.2017.01.079","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T02:30:58Z","timestamp":1486693858000},"page":"1395-1402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Protective efficacy of a lipid antigen vaccine in a guinea pig model of tuberculosis"],"prefix":"10.1016","volume":"35","author":[{"given":"G\u00e9rald","family":"Larrouy-Maumus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Layre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Prandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Lepore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"de Libero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germain","family":"Puzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Gilleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.01.079_b0005","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.01.079_b0010","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/imr.12270","article-title":"Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool","volume":"264","author":"Karp","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2017.01.079_b0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.smim.2013.04.006","article-title":"Tuberculosis vaccines: time to think about the next generation","volume":"25","author":"Kaufmann","year":"2013","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2017.01.079_b0020","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","article-title":"Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns","volume":"182","author":"Kagina","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2017.01.079_b0025","doi-asserted-by":"crossref","first-page":"11290","DOI":"10.1038\/ncomms11290","article-title":"T-cell activation is an immune correlate of risk in BCG vaccinated infants","volume":"7","author":"Fletcher","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2017.01.079_b0030","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-immunol-032414-112008","article-title":"The immunology of CD1- and MR1-restricted T cells","volume":"34","author":"Mori","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2017.01.079_b0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fimmu.2014.00219","article-title":"The T-cell response to lipid antigens of mycobacterium tuberculosis","volume":"5","author":"De Libero","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2017.01.079_b0040","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/imr.12253","article-title":"CD1 and mycobacterial lipids activate human T cells","volume":"264","author":"Van Rhijn","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2017.01.079_b0045","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/372691a0","article-title":"Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells","volume":"372","author":"Beckman","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.01.079_b0050","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1084\/jem.20031097","article-title":"Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis","volume":"199","author":"Gilleron","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2017.01.079_b0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.chembiol.2008.11.008","article-title":"Mycolic acids constitute a scaffold for mycobacterial lipid antigens stimulating CD1-restricted T cells","volume":"16","author":"Layre","year":"2009","journal-title":"Chem Biol"},{"key":"10.1016\/j.vaccine.2017.01.079_b0060","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1126\/science.278.5336.283","article-title":"Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells","volume":"278","author":"Moody","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.01.079_b0065","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.7542404","article-title":"CD1-restricted T cell recognition of microbial lipoglycan antigens","volume":"269","author":"Sieling","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.01.079_b0070","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/35009119","article-title":"CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection","volume":"404","author":"Moody","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.01.079_b0075","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1172\/JCI46216","article-title":"A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection","volume":"121","author":"Montamat-Sicotte","year":"2011","journal-title":"J Clin Investig"},{"key":"10.1016\/j.vaccine.2017.01.079_b0080","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1016\/j.vaccine.2009.05.078","article-title":"The mycobacterial glycolipid glucose monomycolate induces a memory T cell response comparable to a model protein antigen and no B cell response upon experimental vaccination of cattle","volume":"27","author":"Nguyen","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.079_b0085","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4049\/jimmunol.169.1.330","article-title":"Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens","volume":"169","author":"Hiromatsu","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.01.079_b0090","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/intimm\/dxg091","article-title":"Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis","volume":"15","author":"Dascher","year":"2003","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2017.01.079_b0095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.tube.2009.08.004","article-title":"Evaluation of new vaccines for tuberculosis in the guinea pig model","volume":"89","author":"Williams","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2017.01.079_b0100","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1126\/science.1115301","article-title":"Assistance of microbial glycolipid antigen processing by CD1e","volume":"310","author":"de la Salle","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.01.079_b0105","doi-asserted-by":"crossref","first-page":"29880","DOI":"10.1074\/jbc.M303446200","article-title":"Acylation state of the phosphatidylinositol hexamannosides from Mycobacterium bovis bacillus Calmette Guerin and Mycobacterium tuberculosis H37Rv and its implication in Toll-like receptor response","volume":"278","author":"Gilleron","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2017.01.079_b0110","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1189\/jlb.69.6.1036","article-title":"Different Toll-like receptor agonists induce distinct macrophage responses","volume":"69","author":"Jones","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2017.01.079_b0115","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1194\/jlr.M013482","article-title":"Deciphering sulfoglycolipids of Mycobacterium tuberculosis","volume":"52","author":"Layre","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1016\/j.vaccine.2017.01.079_b0120","doi-asserted-by":"crossref","first-page":"21257","DOI":"10.1074\/jbc.M400324200","article-title":"The role of MmpL8 in sulfatide biogenesis and virulence of Mycobacterium tuberculosis","volume":"279","author":"Domenech","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2017.01.079_b0125","doi-asserted-by":"crossref","first-page":"34896","DOI":"10.1074\/jbc.M103908200","article-title":"Acylation state of the phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette Guerin and ability to induce granuloma and recruit natural killer T cells","volume":"276","author":"Gilleron","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2017.01.079_b0130","doi-asserted-by":"crossref","first-page":"31494","DOI":"10.1074\/jbc.M112.386300","article-title":"Deciphering the role of CD1e protein in mycobacterial phosphatidyl-myo-inositol mannosides (PIM) processing for presentation by CD1b to T lymphocytes","volume":"287","author":"Cala-De Paepe","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2017.01.079_b0135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbamem.2005.10.011","article-title":"Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses","volume":"1718","author":"Davidsen","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2017.01.079_b0140","doi-asserted-by":"crossref","first-page":"34426","DOI":"10.1074\/jbc.M111.257444","article-title":"Proteolipidic composition of exosomes changes during reticulocyte maturation","volume":"286","author":"Carayon","year":"2011","journal-title":"J Biol Chem"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2017.01.079_b0145","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.1086\/313878","article-title":"Comparison of the protective efficacy of bacille calmette-Guerin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis","volume":"30","author":"Williams","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.01.079_b0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tube.2011.09.003","article-title":"Assessment of vaccine testing at three laboratories using the guinea pig model of tuberculosis","volume":"92","author":"Grover","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2017.01.079_b0155","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.4049\/jimmunol.0804044","article-title":"Fatty acyl structures of Mycobacterium tuberculosis sulfoglycolipid govern T cell response","volume":"182","author":"Guiard","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.01.079_b0160","doi-asserted-by":"crossref","first-page":"9734","DOI":"10.1002\/anie.200803835","article-title":"Synthesis of diacylated trehalose sulfates: candidates for a tuberculosis vaccine","volume":"47","author":"Guiard","year":"2008","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.vaccine.2017.01.079_b0165","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/cbic.201300482","article-title":"Simplified deoxypropionate acyl chains for Mycobacterium tuberculosis sulfoglycolipid analogues chain length is essential for high antigenicity","volume":"14","author":"Gau","year":"2013","journal-title":"Chembiochem Eur J Chem Biol"},{"key":"10.1016\/j.vaccine.2017.01.079_b0170","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coi.2014.01.009","article-title":"Challenges and responses in human vaccine development","volume":"28","author":"Kaufmann","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2017.01.079_b0175","doi-asserted-by":"crossref","first-page":"e1002607","DOI":"10.1371\/journal.ppat.1002607","article-title":"Vaccines against tuberculosis: where are we and where do we need to go?","volume":"8","author":"Ottenhoff","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2017.01.079_b0180","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0002-2015","article-title":"Mouse and guinea pig models of tuberculosis","volume":"4","author":"Orme","year":"2016","journal-title":"Microbiol Spectrum"},{"key":"10.1016\/j.vaccine.2017.01.079_b0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.01.079_b0190","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1016\/j.vaccine.2013.07.032","article-title":"Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens","volume":"31","author":"Derrick","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.079_b0195","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.tube.2006.01.014","article-title":"Re-formulation of selected DNA vaccine candidates and their evaluation as protein vaccines using a guinea pig aerosol infection model of tuberculosis","volume":"86","author":"Vipond","year":"2006","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2017.01.079_b0200","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0882-4010(87)90077-5","article-title":"Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG","volume":"2","author":"De Bruyn","year":"1987","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2017.01.079_b0205","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/10611860802228558","article-title":"Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres","volume":"16","author":"Kirby","year":"2008","journal-title":"J Drug Target"},{"key":"10.1016\/j.vaccine.2017.01.079_b0210","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2009.10.022","article-title":"Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen","volume":"142","author":"Henriksen-Lacey","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2017.01.079_b0215","doi-asserted-by":"crossref","first-page":"e53531","DOI":"10.1371\/journal.pone.0053531","article-title":"The Mincle-activating adjuvant TDB induces MyD88-dependent Th1 and Th17 responses through IL-1R signaling","volume":"8","author":"Desel","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.01.079_b0220","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tube.2004.11.001","article-title":"An assay to compare the infectivity of Mycobacterium tuberculosis isolates based on aerosol infection of guinea pigs and assessment of bacteriology","volume":"85","author":"Williams","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2017.01.079_b0225","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.vaccine.2015.03.083","article-title":"Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system","volume":"33","author":"Bottai","year":"2015","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T05:04:28Z","timestamp":1692680668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17301597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0264410X17301597"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.079","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective efficacy of a lipid antigen vaccine in a guinea pig model of tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}